Aristotle University Of Thessaloniki (AUTH)
Οι μεταβολές των πεπτιδίων του εντεροϊνσουλινικού άξονα μετά από την ενδοεγκεφαλοκοιλιακή έγχυση του νευροπεπτιδίου Ορεξίνη-Α: πειραματική μελέτη σε χοίρους
Abstract
dc:descriptionHypothalamus plays a primary role in maintaining metabolism and energy homeostasis with the main aim of keeping the harmonious function of the organism. It is the common area of production and (potentially) of action of a large number of neuropeptides, whose total number and complete recording of properties remains a field of active research with conflicting and ambiguous results. The neuropeptide Orexin-A is produced by a small cluster of neurons round the nucleus of the fornix (posterior hypothalamus), the paraventricular and dorsomedial nuclei, the ventromedial hypothalamus, as well as the lateral hypothalamic region; these are sites known to be involved in regulating feeding in mammals. Orexin-A was initially isolated in 1998 from the extracts of the cerebral tissue of rats. The impressive dispersion of the axes from the aforementioned neurons that produce Orexin-A, as well as the existence of the corresponding neuropeptide receptors in many organs, render it a significant regulatory factor, not only in the appetite phenomenon, but also in a variety of other normal functions. Targeting the pancreas, Orexin-A seems to play are gulatory/mediatory role in the functional linkage of hypothalamus, pancreas, and intestine and, by extension, at the enteroinsular axis, which expresses the functional linkage between the GI tract and the pancreatic islets. The aim of our study was to carry out an i.c.v. injection of the neuropeptide Orexin-A of porcine origin in the pig’s brain in two different ways of administration (rapid and slow injection – duration: 15 minutes), in two different doses of Orexin-A (5 and 10mg), and also combined with a simultaneous glucose administration. Any changes in insulin, glucagon, GIP, and C-peptide concentrations were recorded in the peripheral blood of the pigs at five successive time periods (15 minutes prior to the injection, in the beginning of the rapid or slow injection, and after 5, 15, and 30 minutes). Through this experimental protocol, an attempt was made to understand the principles of function and determine the degree of participation/effect of Orexin-A in the function of the enteroinsular axis, since the properties of all four peptides are directly or indirectly involved with the axis. A novel subcutaneous epicranial valve was placed on the experimental animals, thus allowing multiple catheterizations. Finally, eleven healthy pigs weighing 10 kg each, approximately, were used in our study, instead of seven pigs specified in the experimental protocol. In two of these experimental animals, it was impossible to carry out the experiment, because the cerebral parenchyma was heavily injured due to the incorrect and hasty placement of the lumbar puncture tube causing the sudden death of the pigs. The other two pigs were used as follows: One was used to perform a CT scan of the brain in vivo and the other was used to take photographs of the cerebral parenchyma. Plasma insulin levels presented a statistically significant increase throughout the experiment, both in the 5mg dose and the 10mg dose, in both ways of administration (rapid and slow injection). Similarly, with the simultaneous intravenous glucose administration, an even larger statistical increase in insulin levels was seen throughout the experiment in both doses of the neuropeptide mentioned above, in both different ways of administration, respectively. Plasma glucagons levels presented a statistically significant increase from the beginning of the experiment until the end, both for the 5mg dose and the 10mg dose, in both ways of administration (rapid and slow injection). With the simultaneous intravenous glucose administration, a statistically significant increase in glucagon concentrations was noted during the first 15 minutes of the experiment. Subsequently, its values presented a gradual decrease until the end of the experiment. This behavior was noted in both doses of Orexin-A, and in both ways of administration, respectively. Plasma GIP levels presented a statistically significant increase throughout the experiment in both doses of 5 and 10 mg, in both ways of administration (rapid and slow injection). Similarly, with the simultaneous intravenous glucose administration, there was a statistically significant increase in GIP levels throughout the experiment, which was even larger, in both doses of the neuropeptide as mentioned above, in both different ways of administration, respectively. Plasma C-peptide levels presented a statistically significant increase from the beginning of the experiment until the end, in both doses of 5 and 10mg, in both ways of administration (rapid and slow injection). Similarly, with the simultaneous intravenous glucose administration, there was an even larger statistical increase in C-peptide levels throughout the experiment, in both doses of 5 and 10mg of the neuropeptide administered, both for the rapid and the slow injection. The i.c.v. injection of porcine Orexin-A affects insulin, glucagon, GIP, and C-peptide concentrations in the peripheral blood of the pig in a time- and dose-dependent way, thus causing eventually an increase in their concentrations. It is well known and accepted that all four hormones examined are directly or indirectly involved in the function of the enteroinsular axis. Based on the above experimental data, probably an i.c.v. injection of porcine Orexin A seems to play a regulatory/mediatory role in the function of the enteroinsular axis in pigs.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Παπακωνσταντίνου, Παντελεήμων
- Papakonstantinou, Panteleimon
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19372